semaglutide and osteoarthritis alleviates independent of weight loss via GLP-1R–mediated activation of autophagy through AKT/mTOR inhibition New Insight on How Semaglutide
Description
"GLP-1 isn't a strategy," she explains
Principal component analysis (PCA) was performed using R 30
Correspondence to Sonali Paul, MD, MS, Associate Editor
Balance between on- and off-target effects of the dual GLP1/E agonist, and the concurrence of desensitization at very high doses, might contribute to this phenomenon
For a deeper comparison of the two drug families, see /articles/comparison/difference-between-ozempic-mounjaro/
This phenomenon, sometimes called tachyphylaxis, reflects complex interactions between metabolic adaptation, receptor sensitivity, and individual genetic architecture
